Page last updated: 2024-10-30

metaproterenol and Ventricular Dysfunction, Left

metaproterenol has been researched along with Ventricular Dysfunction, Left in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunetti, ND1
Ieva, R1
Correale, M1
De Gennaro, L1
Pellegrino, PL1
Dioguardi, E1
D'Arienzo, G1
Ziccardi, L1
Di Biase, M1

Other Studies

1 other study available for metaproterenol and Ventricular Dysfunction, Left

ArticleYear
Combined exogenous and endogenous catecholamine release associated with Tako-Tsubo like syndrome in a patient with atrio-ventricular block undergoing pace-maker implantation.
    Acute cardiac care, 2011, Volume: 13, Issue:2

    Topics: Adrenergic beta-2 Receptor Agonists; Aged; Atrioventricular Block; Catecholamines; Diuretics; Echoca

2011